
    
      This double-blind, placebo-controlled pilot study will determine the ability of
      dextroamphetamine to treat comorbid cocaine dependence and ADHD. Participants will be
      randomly assigned on receive placebo or Dextroamphetamine SR (60 mg/day) during a 12-week
      study period. All participants will receive weekly cognitive behavioral therapy.
    
  